Previous 10 | Next 10 |
The following slide deck was published by NovoCure Limited in conjunction with this Read more ...
Medical science has come a long way from the days when plague doctors wore scary, long-beaked masks and prescribed a steady treatment of leeches and stabbing to cure a head cold. These days, leading American healthcare stocks employ state-of-the-art technology to excel at both saving live...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...
Recently, the DOW plunged 800 points—about 3 percent overall—due to fears that a so-called “recession 2019” might be similar to the one experienced in 2008. Exasperating those fears is the fact that the benchmark 10-year Treasury bond yield broke below the two-...
Race car driver Mikaela Ahlin-Kottulinsky and her helmet (photo via Forbes ). Bulletproof Investing: Week 91 Performance Each week, since the beginning of June 2017, I have presented at least two hedged portfolios created by Portfolio Armor to my Bulletproof Investing subscribers. This ...
Image via Retail Detail . Alibaba And The Hedged Portfolio Method One of the great new tools Seeking Alpha has added to its Essential offering is its Quant Ratings, which take into account value, growth, profitability, momentum, and EPS revisions. There's an interesting contrast betw...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...
The following slide deck was published by NovoCure Limited in conjunction with this Read more ...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...
SHANGHAI, China and ST. HELIER, Jersey, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform technology called Tumor Treati...
News, Short Squeeze, Breakout and More Instantly...
2024-08-02 13:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-25 17:30:15 ET Image source: The Motley Fool. NovoCure (NASDAQ: NVCR) Q2 2024 Earnings Call Jul 25, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: NovoCure (NVCR) Q2 2024 Earnings Call Transcript
Quarterly net revenues of $150 million, up 19% year-over-year, with 3,963 active patients on therapy as of June 30, 2024 Positive results from Phase 3 METIS trial in brain metastases from non-small cell lung cancer presented at ASCO 2024 Novocure (NASDAQ: NVCR) today reported fi...